Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Diabetes Transition Coordinator Study

Key facts

Where
Calgary, CanadaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 17 and 18 years old?

Where in Canada

  • Alberta Children's HospitalCalgary, CanadaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Calgary
Trial code
NCT06300047
Record updated
1 May 2026
Original description
The goal of this interventional study is to assess the effects and evaluate the implementation of a pediatric to adult care transition intervention in youth with T1D on clinical, patient-reported, and implementation outcomes, including an economic analysis.Read full original descriptionShow less

Aiming for Something Sweeter: Supporting Youth With Type 1 Diabetes During Transition From Pediatric to Adult Diabetes Care

The goal of this interventional study is to assess the effects and evaluate the implementation of a pediatric to adult care transition intervention in youth with T1D on clinical, patient-reported, and implementation outcomes, including an economic analysis.

The 3 main aims are:

1. To assess the effects of our transition intervention on clinical and patient-reported outcomes. 2. To implement the transition intervention and evaluate the implementation outcomes. 3. To evaluate the economic impacts of the transition intervention. Participants will have access to a transition coordinator before, during, and after their planned transition from pediatric to adult care as standard of care.

Researchers will compare a pre-intervention cohort to evaluate the impact of the transition coordinator intervention.

Inclusion: a diagnosis of T1D according to Diabetes Canada's guidelines for at least 12 months; aged 17 to 18 years; have had an appointment with their pediatric endocrinologist in the last 12 months; in the last year of pediatric care and transferring to adult care in Alberta within the next year; English proficiency (for surveys); Personal Health Number (PHN) for data linkage.

Exclusion: -.

ClinicalTrials.gov NCT06300047